145 related articles for article (PubMed ID: 30456681)
21. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
[TBL] [Abstract][Full Text] [Related]
22. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
[TBL] [Abstract][Full Text] [Related]
23. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
[TBL] [Abstract][Full Text] [Related]
24. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
[TBL] [Abstract][Full Text] [Related]
25. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
26. A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.
Bhutiani N; Egger ME; Stromberg AJ; Gershenwald JE; Ross MI; Philips P; Martin RCG; Scoggins CR; McMasters KM
J Surg Oncol; 2018 Nov; 118(6):922-927. PubMed ID: 30259521
[TBL] [Abstract][Full Text] [Related]
27. Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.
Ngô C; Mouttet D; De Rycke Y; Reyal F; Fourchotte V; Hugonnet F; Falcou MC; Bidard FC; Vincent-Salomon A; Fourquet A; Alran S
Eur J Surg Oncol; 2012 Dec; 38(12):1211-7. PubMed ID: 22954526
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
[TBL] [Abstract][Full Text] [Related]
29. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
30. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
[TBL] [Abstract][Full Text] [Related]
31. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
32. T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node.
Noda S; Onoda N; Asano Y; Kurata K; Kashiwagi S; Kawajiri H; Takashima T; Hirakawa K
Int J Surg; 2015 Feb; 14():56-60. PubMed ID: 25597234
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
34. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
35. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
36. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
37. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
[TBL] [Abstract][Full Text] [Related]
38. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
Verver D; van Klaveren D; Franke V; van Akkooi ACJ; Rutkowski P; Keilholz U; Eggermont AMM; Nijsten T; Grünhagen DJ; Verhoef C
Br J Surg; 2019 Feb; 106(3):217-225. PubMed ID: 30307046
[TBL] [Abstract][Full Text] [Related]
40. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
